Peer Review History: Newer Oral Antiviral for the Treatment of COVID-19 Infection

Editor(s):

(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Japan.

(2) Prof. Syed A. A. Rizvi, Larkin University, USA.

(3) Prof. Alyautdin Renad N, Sechenov University, Russia.

Reviewers:

(1) Attapon  Cheepsattayakorn, Western  University, Thailand.

(2) Soheil Haddadzadegan, University of Innsbruck, Austria.

(3) Gopinath Ramalingam, Govt. Theni Medical College, India.

(4) M.Sri Ramachandra, Dr. KV Subba Reddy Institute of Pharmacy, India.

(5) Essam Fadel Alwan Al-Jumaili, University of Baghdad, Iraq.

Additional Reviewers:

Additional Reviewers: (Comments received after deadline)

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.22/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer Review Report_1 (Attapon Cheepsattayakorn, Thailand) | File 1 | NA


Stage 2 | Peer Review Report_2 (Soheil Haddadzadegan, Austria) | File 1 | NA


Stage 2 | Peer Review Report_3 (Gopinath Ramalingam, India) | File 1 | NA


Stage 2 | Peer Review Report_4 (M. Sri Ramachandra, India) | File 1 | NA


Stage 2 | Peer Review Report_5 (Essam Fadel Alwan Al-Jumaili, Iraq) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


Stage 3 | Comment_Editor_3_v1 | File 1 | NA


Posted in Review History.